Literature DB >> 18582444

Callosal function in MS patients with mild and severe callosal damage as reflected by diffusion tensor imaging.

Nele P Warlop1, Els Fieremans, Eric Achten, Jan Debruyne, Guy Vingerhoets.   

Abstract

In this study, callosal function was behaviourally tested in MS patients with a redundant stimuli task. Reaction times to uni- and bilateral visual stimuli are recorded. Normal subjects respond faster to bilateral than to unilateral stimuli. This effect is called the redundancy gain effect. In patients with agenesis of the corpus callosum, the redundancy gain exceeds that predicted by probability summation, suggesting a mediating influence of the corpus callosum in healthy controls. The aim of this study is to investigate the effect of callosal damage on the redundancy gain in MS patients by investigating the probability summation model. Seventeen MS patients and as many matched healthy controls performed the redundancy gain task. In order to objectify callosal damage in our MS group, diffusion tensor imaging (DTI) derived measures such as fractional anisotropy (FA) and mean diffusivity (MD) in the corpus callosum were obtained. Callosal FA and MD significantly differed in our MS group compared to the healthy controls, indicating pathological callosal involvement. Since the amount of callosal damage was highly variable within the MS group, the MS cohort was split into a low and a high callosal-injured group as quantified by FA. The high FA group performed like the healthy controls, whereas violations of the probability (race) model were found for the low FA group. We conclude that behavioural measures obtained by the redundancy gain paradigm reflect callosal pathology in MS as measured by DTI.

Entities:  

Mesh:

Year:  2008        PMID: 18582444     DOI: 10.1016/j.brainres.2008.06.006

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability.

Authors:  Hormuzdiyar H Dasenbrock; Seth A Smith; Arzu Ozturk; Sheena K Farrell; Peter A Calabresi; Daniel S Reich
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

2.  Fractional anisotropy and mean diffusivity in the corpus callosum of patients with multiple sclerosis: the effect of physiotherapy.

Authors:  Ibrahim Ibrahim; Jaroslav Tintera; Antonin Skoch; Filip Jirů; Petr Hlustik; Patricia Martinkova; Karel Zvara; Kamila Rasova
Journal:  Neuroradiology       Date:  2011-05-10       Impact factor: 2.804

3.  White matter characterization with diffusional kurtosis imaging.

Authors:  Els Fieremans; Jens H Jensen; Joseph A Helpern
Journal:  Neuroimage       Date:  2011-06-13       Impact factor: 6.556

4.  An animal model of cortical and callosal pathology in multiple sclerosis.

Authors:  Mario Mangiardi; Daniel K Crawford; Xiaoyu Xia; Sienmi Du; Rebecca Simon-Freeman; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2010-11-10       Impact factor: 6.508

5.  Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.

Authors:  Daniel K Crawford; Mario Mangiardi; Bingbing Song; Rhusheet Patel; Sienmi Du; Michael V Sofroniew; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain       Date:  2010-09-21       Impact factor: 13.501

6.  Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.

Authors:  Spencer Moore; Anna J Khalaj; Rhusheet Patel; JaeHee Yoon; Daniel Ichwan; Liat Hayardeny; Seema K Tiwari-Woodruff
Journal:  J Neurosci Res       Date:  2014-07-03       Impact factor: 4.164

7.  Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model.

Authors:  P Cruz-Martinez; S González-Granero; M M Molina-Navarro; J Pacheco-Torres; J M García-Verdugo; E Geijo-Barrientos; J Jones; S Martinez
Journal:  Cell Death Dis       Date:  2016-05-12       Impact factor: 8.469

8.  Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.

Authors:  Spencer Moore; Anna J Khalaj; Jaehee Yoon; Rhusheet Patel; Gemmy Hannsun; Timothy Yoo; Manda Sasidhar; Leonardo Martinez-Torres; Liat Hayardeny; Seema K Tiwari-Woodruff
Journal:  Brain Behav       Date:  2013-09-23       Impact factor: 2.708

Review 9.  How changes in brain activity and connectivity are associated with motor performance in people with MS.

Authors:  Daniel S Peterson; Brett W Fling
Journal:  Neuroimage Clin       Date:  2017-09-28       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.